Clinical Trials Directory

Trials / Completed

CompletedNCT02703597

Smoking Prevention Through Social Connections Among Adolescents - ASPIRE

Social Influence Strategies During a Web-based Smoking Prevention Intervention for Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
393 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
11 Years – 18 Years
Healthy volunteers
Accepted

Summary

The central hypothesis of this study is that the addition of social influence strategies to a web-based program called ASPIRE will boost its success in lowering intention to use tobacco among adolescents and experiencing stronger positive social influence. The study will involve a nested group randomized controlled trial with adolescents from after-school programs and schools (e.g., the PK Yonge school) in Florida.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSurveysSurveys include questions related to tobacco use behavior and attitude toward tobacco, as well as demographic and personality questions. Psychosocial surveys and social network surveys are also completed to capture adolescents' network of friends and opinion leaders.
BEHAVIORALASPIREParticipants engage in four to five 70-minute sessions of ASPIRE spread over a period of 4 weeks. During ASPIRE use, participants face a screen and individually watch videos and engage in computer-based activities related to the negative effects of tobacco.
BEHAVIORALGSA-ASPIRE-NetworkIn groups, participants engage in four to five 70-minute sessions of ASPIRE conducted over a period of 4 weeks. However, during each session, ASPIRE use is coupled with game-based social activities (GSAs). During ASPIRE use, participants watch videos and engage in computer-based activities on the same computer screen. Also, in groups, participants engage in the paper-based GSAs as a team and collaborate as they complete the activities. The GSAs contain games about the effects of tobacco. Groups are allocated based on adolescents' network of friendships.

Timeline

Start date
2021-06-01
Primary completion
2022-03-16
Completion
2022-03-16
First posted
2016-03-09
Last updated
2024-10-23
Results posted
2024-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02703597. Inclusion in this directory is not an endorsement.